2016 Cancer Summit

 

Program Description

Cancer treatment guidelines change rapidly; common treatment one year ago, is no longer standard treatment today. Changes in guidelines are challenging to keep up with as physicians struggle with time constraints and patient load to have opportunities to discuss the latest updates. The standard of care for cancer treatment requires a multidisciplinary approach.

The 2017 Bon Secours Cancer Summit conference is a forum to bridge the gap between independent providers. At this summit a review of updates to NCCN guidelines and changes to treatment recommendations are evaluated with 360° input so ny can benefit from research and time spent by individual clinicians. Using a conference to review, evaluate and apply new technology and research results using a multidisciplinary approach allows for adherence to guidelines and ensures patients receive timely treatment resulting in improved quality of care. The mission to provide Good Help to Those in Need® takes on special meaning in the care of our cancer patients and their families. We strive to provide an environment where healing and hope can flourish.

For the 2017 Bon Secours Cancer Summit,we have chosen the following topics due tothe timeliness with what the public is seeingin the media and the need for primary care and medical oncology physicians to have the ability to speak with their patients and answer questions on these topics and to address gaps in the literature: Palliative Care, Cancer Rehabilitation, Cancer Survivorship, Gynecological Oncology, Cancer Research, and Colorectal Cancer.

Target Audience

Primary care physicians, specialists, surgeons, medical oncologists, radiation oncologists, nurse practitioners and other healthcare professionals interested in a deeper knowledge and understanding of the full continuum of cancer care including healthy survivorship.

Educational Objectives

At the end of the summit, participants will be able to:

    •  Identify ways Cancer Rehabilitation can help their patients
    •  Describe patient care management through survivorship care plans
    •  Articulate the role of palliative care for their patients
    •  Differentiate and discuss the differences in colorectal cancer screening options
    •  Understand ways to bridge gaps in clinical trial enrollment of the underserved population
    •  Explain the role the HPV virus is playing in cervical cancer

Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Virginia School of Medicine and Bon Secours Cancer Institute.

The University of Virginia School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Virginia School of Medicine designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Virginia School of Medicine awards 6 hours of participation (equivalent to AMA PRA Category 1 Credit(s)™) to each non-physician participant who successfully completes this educational activity. Bon Secours Cancer Institute maintains a permanent record of participants who have been awarded CEUs.

The University of Virginia School of Nursing Continuing Education (SONCE) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. The University of Virginia SONCE awards 6 contact hours for nurses who participate in this educational activity and complete the post activity evaluation.

Disclosure of Faculty Financial Affiliations

The University of Virginia School of Medicine, as an ACCME accredited provider, and The University of Virginia School of Nursing Continuing Education as an ANCC accredited provider, endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support and with the American Nurses Credentialing Center (ANCC) Content Integrity Standards, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing education activities under our auspices.

The University of Virginia School of Medicine and School of Nursing require that all CE activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.

All faculty presenters participating in an accredited CE activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.). The University of Virginia School of Medicine and School of Nursing will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, University of Virginia School of Medicine or the University of Virginia School of Nursing Continuing Education, Charlottesville, Virginia.

The faculty, staff and planning committee of the University of Virginia Office of Continuing Medical Education and the University of Virginia School of Nursing Continuing Education have no financial affiliations to disclose.

Disclosure of discussion of non-FDA-approved uses for Pharmaceutical products and/or medical devices.

The University of Virginia School of Medicine and the University of Virginia School of Nursing Continuing Education requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. It is recommended that each clinician fully review all the available data on new products or procedures prior to clinical use.

The following faculty and staff have reported an affiliation to disclose:

• James V. Pellicane, MD—the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Agendia; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Focal Therapeutics; the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Dune Medical; the following faculty member has disclosed a Commercial Interest in Caris Life Sciences.

•Thomas Smith, MD-the following faculty has disclosed Speakers Bureau, Faculty, Peer Reviewer for Care Symptom Management; the following faculty member has disclosed Commercial Interest in GEOMC, Inc., Seoul Korea; the following faculty member has disclosed Clinical/Researcher for Neuromodulation.

The following faculty has disclosed no financial relationship or interest with any propriety entity producing healthcare goods or services:

• Marylou S. Anton, MSN, RN, OCN*
• Beth L. Brew, BSRT (R)(T), MBA*
• William Irvin, Jr., MD*
• Ryan Stuhlreyer, MBA*
• George Parker, MD*
• James V. Pellicane, MD*
• Bradley Prestidge, MD, MS*
• Kathryn Reid, PhD, APRN, FNP*
• George Bousaba, MD*
• Andrew Vorenberg, MD
• Carrie Riddock, MSPT, CLT-LANA
• Thomas Smith, MD
• Christopher McCann, DO
• Joseph Hall, MA
• Charles Kamen, PhD
• Deborah Mayer, PhD, RN
*denotes Planning Committee

Overview
Bon Secours Facility
Agenda
Register
Venue
Exhibit and Sponsor
Contac Us
Bon Secours Cancer Facilities
2015 Hope Awards